Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Long LLY ETF

29.50
+0.49501.71%
Volume:79.71K
Turnover:2.33M
Market Cap:46.46M
PE:- -
High:29.60
Open:29.05
Low:28.83
Close:29.01
52wk High:31.19
52wk Low:12.18
Shares:1.57M
Float Shares:1.57M
Volume Ratio:1.06
T/O Rate:5.06%
Dividend:0.70
Dividend Rate:2.39%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Lilly Stock Jumps on Strong GLP-1 Sales

Dow Jones
·
Aug 05

Eli Lilly CFO Says Injectable Glp-1 Drugs Remain Key Growth Driver, Account for Three Out of Four New Patient Starts: Conf Call

THOMSON REUTERS
·
Aug 05

Eli Lilly Shares Surge Nearly 6% at Market Open

Deep News
·
Aug 05

Market Movers | Shopify Surges 18%; Dynatrace Pops 14%; Eli Lilly Jumps 7%; Disney Rises 3%; Circle Falls 3%; Uber Drops 5%

Tiger Newspress
·
Aug 05

Eli Lilly Lifts Annual Revenue Forecast After Blockbuster Drug Sales Surge Overseas

Deep News
·
Aug 05

Eli Lilly and Company Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

Sector Update: Healthcare

MT Newswires Live
·
Aug 05

Eli Lilly Posts Q2 Revenue Growth Driven by Soaring GLP-1 Drug Demand

Deep News
·
Aug 05

Eli Lilly raises annual revenue forecast as GLP-1 drugs fuel growth

Bloomberg
·
Aug 05

U.S. Stocks on the MOVE-Arista Networks, CVS, Eli Lilly, Phillips 66

Reuters
·
Aug 05

US Stocks-S&P 500, Dow Futures Inch up as Mideast Hopes Offset SpaceX, AMD Drag

Reuters
·
Aug 05

Eli Lilly's second-quarter revenue hits $22.97 billion, surpassing expectations of $20.59 billion

Deep News
·
Aug 05

Eli Lilly's stock surges 6% in pre-market trading after strong Q2 earnings beat

Deep News
·
Aug 05

Weight Loss Drug Demand Surges, Eli Lilly's Q2 Revenue Soars 48% Year-Over-Year, Full-Year Guidance Raised to $85-87 Billion | Earnings Report

Deep News
·
Aug 05

Lilly's Revenue Soars 48%, Driven by Demand of Its GLP-1s

Dow Jones
·
Aug 05

Lilly Q2 Adjusted EPS USD 8.38 Vs. IBES Estimate USD 6.01

Reuters
·
Aug 05

Lilly Q2 2026 Earnings: Mounjaro and Zepbound Drive 48% Revenue Growth

TradingKey
·
Aug 05

Lilly Beats Estimates on Resilient Demand for Injectable GLP-1 Drugs, Widens Gap with Novo

Reuters
·
Aug 05

Lilly Climbs on Annual Revenue Forecast Raise

Reuters
·
Aug 05

GUIDANCE: (LLY) Eli Lilly Expects 2026 Revenue Range $85B to $87B, vs. FactSet Est of $85.28B

MT Newswires Live
·
Aug 05